Skip to content

Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth

Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02716909
Enrollment
300
Registered
2016-03-23
Start date
2016-03-31
Completion date
2017-07-31
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Birth

Brief summary

Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. In singleton gestations a short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB. The cervical pessary is a silicone device that has been used to prevent SPTB. The efficacy of cervical pessary has been assessed in several populations including singletons with short CL, unselected twins, twins with a short CL, and triplet pregnancies. Several randomized clinical trials (RCTs) have been published, and several are ongoing. However, no consensus on the use of cervical pessary in pregnancy or guidelines for management have been assessed.

Interventions

The cervical pessary is a silicone device that has been used to prevent SPTB Pessary will be placed between 18 and 23 6/7 weeks gestation, and will be removed during the 37th week of pregnancy (or earlier, if indicated)

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* 18-50 years of age * Singleton pregnancy (limits the participants to female gender) * Short cervical length (less than or equal to 25 mm) on second trimester transvaginal ultrasound at 18-23 6/7 weeks gestation

Exclusion criteria

* Multiple gestation * Prior spontaneous preterm birth 16-36 6/7 weeks * Ruptured membranes * Lethal fetal structural anomaly * Fetal chromosomal abnormality * Cerclage in place (or planned placement) * Vaginal bleeding * Suspicion of chorioamnionitis * Ballooning of membranes outside the cervix into the vagina or CL = 0 mm on transvaginal ultrasound * Painful regular uterine contractions * Placenta previa

Design outcomes

Primary

MeasureTime frameDescription
Spontaneous preterm birth (SPTB) <34 weeksLess than 34 weeks gestationSpontaneous preterm delivery less than 34 weeks of gestation

Secondary

MeasureTime frameDescription
SPTB <32wLess than 32 weeks gestation
SPTB <28wLess than 32 weeks gestation
Gestational age at deliveryTime of delivery
Latencytime of deliveryinterval from randomization to delivery in days
preterm premature rupture of membranesLess than 34 weeks gestation
Type of deliverytime of deliveryCesarean delivery, operative vaginal delivery and spontaneous vaginal delivery
SPTB <37wLess than 37 weeks gestation
Birth weightTime of delivery
Neonatal deathBetween birth and 28 days of age
perinatal deathfetal death after 20 weekseither fetal mortality or neonatal death
Composite adverse perinatal outcomeBetween birth and 28 days of ageIncludes necrotizing enterocolitis, Intraventricular hemorrhage (grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia (BPD), retinopathy, blood-culture proven sepsis, and neonatal death
ChorioamnionitisTime of delivery
Adminssion to neonatal intensive care unitBetween birth and 28 days of age
Maternal side effectsTime of deliveryVaginal discharge, bacterial vaginosis

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026